Neurology Book

//fpnotebook.com/

Pyridostigmine

Aka: Pyridostigmine, Pyridostigmine Bromide, Mestinon
  1. Indications
    1. Pretreatment before Nerve Agent Exposure (Soman)
    2. Myasthenia Gravis
      1. Provides symptomatic relief, esp. extremity weakness and bulbar symptoms
      2. Less effective on Ptosis and Diplopia
      3. Unlikely to benefit myasthenia crisis with Respiratory Failure and may interfere with respiratory management
  2. Physiology
    1. Pyridostigmine is an Anticholinesterase
    2. Results in increased Cholinergic effects
  3. Pharmacokinetics: Nerve Agent Exposure
    1. Significantly enhances post-exposure antidote for Soman
    2. Does not enhance antidote for other Nerve Agents
    3. Raises SomanLD50 by several fold
  4. Dosing: Nerve Agent Exposure
    1. Pyridostigmine 30 mg PO every 8 hours before exposure
  5. Dosing: Myasthena Gravis
    1. Child: 0.5 to 1 mg/kg every 4-6 hours (maximum 7 mg/kg/day divided every 4 to 6 hours)
    2. Adult
      1. Starting Dose: 30 mg three times daily
      2. Typical Dose: 60 to 90 mg every 4 to 6 hours while awake
      3. Maximum Dose: 120 mg every 4 hours while awake
    3. Pharmacokinetics
      1. Onset: 15-30 minutes
      2. Peaks: 2 hours
      3. Duration: 3-4 hours
  6. Adverse Effects
    1. Risk of Cholinergic Toxicity
    2. Risk of worsening myasthenia crisis (due to mucous plugging, bronchorrhea)
  7. Precautions: Nerve Agent Exposure
    1. Pyridostigmine does not protect against exposure
    2. Nerve Agent Exposures must be treated with Antidote
  8. References
    1. (1998) USAMRICD Chemical Casualties Handbook, p. 58-9
Medication Costs
pyridostigmine (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
PYRIDOSTIGMINE BR 60 MG TABLET Generic $0.51 each
PYRIDOSTIGMINE ER 180 MG TAB Generic $10.93 each
mestinon (on 10/13/2016 at Medicaid.Gov Pharmacy Drug pricing)
MESTINON 180 MG TIMESPAN Generic $10.93 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Pyridostigmine (C0034261)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D011729
SnomedCT 373344003, 59953007
LNC LP17869-6, MTHU024724
English PYRIDOSTIGMINE, pyridostigmine, Pyridostigmine (product), Pyridostigmine (substance), Pyridostigmine
Spanish piridostigmina (producto), piridostigmina (sustancia), piridostigmina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree